News tagged with heparin
Nanoscience may hold key to surgical recovery
(PhysOrg.com) -- New nano-systems developed in York may eventually help patients recover from surgery without the danger of allergic reactions to drugs.
Nanotechnology / Bio & Medicine
Apr 27, 2011 |
not rated yet |
0
Toward an improved test for adulterated heparin
Scientists are reporting refinement of a new test that promises to help assure the safety of supplies of heparin, the blood thinner taken by millions of people worldwide each year to prevent blood clots. The ...
Chemistry / Analytical Chemistry
Sep 21, 2011 |
not rated yet |
0
Heparin a key role player in allergy and inflammatory reactions
Heparin plays a key role in allergic and inflammatory reactions driven by mast cells, scientists from Karolinska Institutet in Sweden shows in an international collaboration involving colleagues from Germany and Switzerland. ...
Medicine & Health / Medical research
Feb 25, 2011 |
not rated yet |
0
Canadian researchers discover new way to prevent infections in dialysis patients
Researchers have discovered that a drug used to treat dialysis catheter malfunction in kidney dialysis patients may now also help prevent both malfunction as well as infections.
Medicine & Health / Diseases, Conditions, Syndromes
Jan 26, 2011 |
5 / 5 (1) |
0
Drug trial results refine treatment during angioplasty operations
A landmark international study, coordinated by McMaster University, has found that lower doses of a blood thinner called unfractionated heparin (UFH) during angioplasty did not reduce bleeding or vascular complications compared ...
Medicine & Health / Medical research
Aug 31, 2010 |
not rated yet |
0
Vaccine with no jab: Protein vaccines for needle-free immunization through the skin
(PhysOrg.com) -- Most immunizations currently involve an injection in the arm. In the future, vaccination may be accomplished without the unpleasant jab of a needle: a team led by Victor C. Yang at the University of Michigan ...
Apr 01, 2010 |
4 / 5 (2) |
0
FDA approves generic blood thinner
In a closely watched decision, the Food and Drug Administration on Friday approved an application by German drug-maker Sandoz and Momenta Pharmaceuticals of Cambridge, Mass, to make the first generic version of the widely ...
Medicine & Health / Medications
Jul 26, 2010 |
5 / 5 (1) |
0
Why 'thick' blood protects from a heart attack
"Thick" blood can cause heart attack and stroke, but also prevent them. Scientists at Heidelberg University Hospital have explained the mechanism of this clinical paradox for the first time on an animal model. ...
Medicine & Health / Medical research
Aug 24, 2009 |
4 / 5 (2) |
0
Seaweed extract may hold promise for non-Hodgkin's lymphoma treatment
Seaweed extract may eventually emerge as a lymphoma treatment, according to laboratory research presented at the second AACR Dead Sea International Conference on Advances in Cancer Research: From the Laboratory to the Clinic, ...
Mar 11, 2010 |
5 / 5 (1) |
0
Firefly protein lights pathway to improved detection of blood clots
The enzyme that makes fireflies glow is lighting up the scientific path toward a long-sought new medical imaging agent to better monitor treatment with heparin, the blood thinner that millions of people take to prevent or ...
Dec 08, 2010 |
not rated yet |
0
Blood-thinning copycat enters malaria fight
New treatments for malaria are possible after Walter and Eliza Hall Institute scientists found that molecules similar to the blood-thinning drug heparin can stop malaria from infecting red blood cells.
Medicine & Health / Medical research
Jun 01, 2010 |
not rated yet |
0
Drug study shows improvement in major orthopedic surgery care
An ultra-low-molecular-weight heparin called semuloparin has been found to reduce the incidence of venous thromboembolism in orthopedic surgery patients in a large clinical program being lead by a steering committee chaired ...
Jul 09, 2010 |
not rated yet |
0
Study: Stockings for stroke patients don't work
(AP) -- Special stockings commonly given to stroke patients to prevent blood clots don't work, a new study reported Wednesday.
Medicine & Health / Diseases, Conditions, Syndromes
May 27, 2009 |
5 / 5 (1) |
0
FDA plan aims to increase import safety
(AP) -- U.S. food and drug regulators would share more information with their foreign counterparts as part of a multifaceted strategy to police the safety of millions of imported goods.
Medicine & Health / Medications
Jun 20, 2011 |
not rated yet |
0
Drug-eluting stents better than bare-metal stents for heart attack patients
Late-breaking data from the landmark HORIZONS-AMI clinical trial, presented at the 21st annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium, demonstrated that after two years, in heart attack patients, ...
Sep 25, 2009 |
not rated yet |
0
Heparin
Heparin (from Ancient Greek ηπαρ (hepar), liver), also known as unfractionated heparin, a highly sulfated glycosaminoglycan, is widely used as an injectable anticoagulant, and has the highest negative charge density of any known biological molecule. It can also be used to form an inner anticoagulant surface on various experimental and medical devices such as test tubes and renal dialysis machines.
Although it is used principally in medicine for anticoagulation, its true physiological role in the body remains unclear, because blood anti-coagulation is achieved mostly by heparan sulfate proteoglycans derived from endothelial cells. Heparin is usually stored within the secretory granules of mast cells and released only into the vasculature at sites of tissue injury. It has been proposed that, rather than anticoagulation, the main purpose of heparin is defense at such sites against invading bacteria and other foreign materials. In addition, it is conserved across a number of widely different species, including some invertebrates that do not have a similar blood coagulation system.
For more information about Heparin, read the full article at
Wikipedia.
This text uses material from Wikipedia and is available under the GNU Free Documentation License.